Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Value of team based on current arena deal (unless new arena is pending) without deduction for debt. Compares the number of wins per player payroll relative to the rest of the NBA. Playoff wins count ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results